Welcome to LookChem.com Sign In|Join Free
  • or
3-benzyloxy-4-methoxy-β-ethyl-β-nitrostyrene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

278781-89-8

Post Buying Request

278781-89-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

278781-89-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 278781-89-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,8,7,8 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 278781-89:
(8*2)+(7*7)+(6*8)+(5*7)+(4*8)+(3*1)+(2*8)+(1*9)=208
208 % 10 = 8
So 278781-89-8 is a valid CAS Registry Number.

278781-89-8Relevant academic research and scientific papers

Isoquinoline Derivatives, Methods of Synthesis and Uses Thereof

-

, (2022/01/04)

Described herein are compounds, pharmaceutical compositions and methods of using these compounds and pharmaceutical compositions for treating and/or preventing conditions such as amyotrophic lateral sclerosis. These compounds and pharmaceutical compositions are also useful as antivirals and antimicrobial agents.

Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection

-

, (2015/08/04)

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

-

, (2015/09/23)

The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

-

, (2016/04/26)

The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R6, X and Y are as described in the description and in the claims, as well as or pharmaceutically acceptable salts, or enantiomers, or diastereomers thereof. The invention also contains compositions including the compounds and methods of using the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 278781-89-8